Finance

Lists
BKGI:BKK
Bangkok Genomics Innovation PCL
2,38 ฿
+0,85%
(+0,020) 1D
14-окт., 16:40:00 GMT+7  ·   THB
All symbols
SymbolPriceChange% Change
Generating top insights for BKGI...
Open
2,36 ฿
High
2,38 ฿
Low
2,36 ฿
Mkt. cap
1,43 млд
Avg. vol.
917,11 миң
Volume
307,21 миң
Dividend
2,10%
Quarterly dividend
0,01 ฿
Ex-dividend date
2026-ж., 6-май
P/E ratio
15,02
52-wk high
2,48 ฿
52-wk low
1,20 ฿
EPS
0,16 ฿
Shares outstanding
600,00 млн
No. of employees
109
Open
2,36 ฿
High
2,38 ฿
Low
2,36 ฿
Mkt. cap
1,43 млд
Avg. vol.
917,11 миң
Volume
307,21 миң
Dividend
2,10%
Quarterly dividend
0,01 ฿
Ex-dividend date
2026-ж., 6-май
P/E ratio
15,02
52-wk high
2,48 ฿
52-wk low
1,20 ฿
EPS
0,16 ฿
Shares outstanding
600,00 млн
No. of employees
109
News stories
From web sources and news partners
About Bangkok Genomics Innovation PCL
CEO-
Employees109
Founded2017-ж., 11-сен.
Headquarters-
SectorHealth care provider
Previous reportsAll values in THB
Loading Previous Earnings...
Revenue
Net income
All values in THB
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
88,92 млн
142,26 млн
152,18 млн
155,34 млн
Cost of goods sold
55,20 млн
82,83 млн
87,50 млн
93,99 млн
Cost of revenue
55,20 млн
82,83 млн
87,50 млн
93,99 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26,09 млн
32,35 млн
29,00 млн
28,22 млн
Operating expense
26,12 млн
30,77 млн
28,75 млн
28,02 млн
Total operating expenses
81,32 млн
113,60 млн
116,24 млн
122,00 млн
Operating income
7,60 млн
28,66 млн
35,93 млн
33,33 млн
Other non operating income
-
-
-
-
EBT including unusual items
7,15 млн
28,30 млн
35,55 млн
33,01 млн
EBT excluding unusual items
7,15 млн
28,30 млн
35,55 млн
33,01 млн
Income tax expense
233,00 миң
2,30 млн
4,32 млн
2,19 млн
Effective tax rate
3,26%
8,12%
12,17%
6,64%
Other operating expenses
-1,22 млн
-1,96 млн
-970,00 миң
-908,00 миң
Net income
6,93 млн
26,01 млн
31,23 млн
30,90 млн
Net profit margin
7,79%
18,28%
20,52%
19,89%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-353,00 миң
-354,95 миң
-336,00 миң
-317,00 миң
Net interest expenses
-353,00 миң
-354,95 миң
-336,00 миң
-317,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
11,82 млн
32,52 млн
40,73 млн
37,54 млн
Gain or loss from assets sale
-
-
-
48,00 миң
AI content may include mistakes. Learn more
Google колдонмолору